Results 131 to 140 of about 236,609 (162)

The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines. [PDF]

Vaccines (Basel)
Tulaeva I, Lehmann F, Goldmann N, Dubovets A, Trifonova D, Tulaev M, Cornelius C, Weber M, Focke-Tejkl M, Karaulov A, Henning R, Springer DN, Wiedermann U, Glebe D, Valenta R.   +14 more
europepmc   +1 more source

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac^®) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents. [PDF]

Vaccines (Basel)
Fadlyana E, Rusmil K, Dwi Putra MG, Fulendry FP, Somantri NK, Putri AD, Sari RM, Puspita M, Dewi GP.   +8 more
europepmc   +1 more source

Subclinical infection caused by a recombinant vaccine-like strain poses high risks of lumpy skin disease virus transmission. [PDF]

Front Vet Sci
Shumilova I, Prutnikov P, Mazloum A, Krotova A, Tenitilov N, Byadovskaya O, Chvala I, Prokhvatilova L, Sprygin A.   +8 more
europepmc   +1 more source

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac^®) as a Booster Dose against COVID-19 in Indonesian Adults. [PDF]

Vaccines (Basel)
Rusmil K, Fadlyana E, Girsang RT, Adrizain R, Reza Rahmadi A, Suryadinata H, Dwi Putra MG, Fulendry FP, Nashsyah DT, Utami RK, Zahra Mardiah B, Trisna Windiani IGA, Sugitha Adnyana IGAN, Sukma Pratiwi Murti NL, Agus Somia IK, Utama IMS, Soetjiningsih S, Mutiara ULN, Puspita M.   +18 more
europepmc   +1 more source

Vaccination against Rabbit Hemorrhagic Disease Virus 2 (RHDV2) Using a Baculovirus Recombinant Vaccine Provides Durable Immunity in Rabbits. [PDF]

Viruses
Bosco-Lauth AM, Schueler A, Midthun E, Tyra H, Held A, Hood C, Quilici M, Erickson S, Glover S, Gustafson B, Anderson G.   +10 more
europepmc   +1 more source

Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model. [PDF]

Bioimpacts
Zare H, Bakherad H, Nasr Esfahani A, Norouzi M, Aghamollaei H, Mousavi Gargari SL, Mahmoodi F, Aliomrani M, Ebrahimizadeh W.   +8 more
europepmc   +1 more source

Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in Indonesia. [PDF]

Vaccines (Basel)
Shakinah S, Aini MH, Sekartini R, Soedjatmiko, Medise BE, Gunardi H, Yuniar I, Indawati W, Koesnoe S, Harimurti K, Maria S, Wirahmadi A, Sari RM, Setyaningsih L, Surachman F.   +14 more
europepmc   +1 more source

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults. [PDF]

Sci Rep
Iwata S, Pollard AJ, Tada Y, Omoto S, Shibata RY, Igarashi K, Hasegawa T, Ariyasu M, Sonoyama T.   +8 more
europepmc   +1 more source

In-silico design of a multi-epitope recombinant vaccine against SARS-CoV-2 targeting the receptor-binding domain

, 2022
Pande H, Aranha M.
europepmc   +1 more source

An Attenuated Vaccine Virus of the Neethling Lineage Protects Cattle against the Virulent Recombinant Vaccine-like Isolate of the Lumpy Skin Disease Virus Belonging to the Currently Established Cluster 2.5. [PDF]

Vaccines (Basel)
Shumilova I, Shalina K, Abed Alhussen M, Prutnikov P, Krotova A, Byadovskaya O, Prokhvatilova L, Chvala I, Sprygin A.   +8 more
europepmc   +1 more source